AsortinoBeta
Illumina Inc. logo

ILMNIllumina Inc.

NASDAQStockHealthcareDiagnostics & Research🇺🇸 United StatesISIN US4523271090illumina.com
$218.221.55%
NASDAQ · at close Sep 4, 2026
Tokenized by
Backed Finance logoReality logo
2 issuersOn
Solana logoXLayer logoEthereum logoTON logo
11 chains

Chart data are delayed by 15 minutes.

1D1.55%
1M+7.49%
3M+29.85%
1Y+123.40%
3Y+33.17%
5Y51.96%

Main metrics

$32.95B
$115.97<0.01% of mkt cap
40.64
$5.37
2M
1.47
$88.0052-week range$231.81

About ILMN

Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.

Similar products

Agilent Technologies Inc. logo
ANYSE
$150.86+0.59%
Agilent Technologies Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Charles River Laboratories International, Inc. logo
CRLNYSE
$288.501.65%
Charles River Laboratories International, Inc.
Reality logoDinari Inc. logo
2 issuers · 6 chains
Quest Diagnostics Incorporated logo
DGXNYSE
$237.140.94%
Quest Diagnostics Incorporated
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
Danaher Corp. logo
DHRNYSE
$207.661.60%
Danaher Corp.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 15 chains